Literature DB >> 1310070

p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking.

H Suzuki1, T Takahashi, T Kuroishi, M Suyama, Y Ariyoshi, T Takahashi, R Ueda.   

Abstract

The p53 gene has been implicated as a tumor suppressor gene involved in the pathogenesis of lung cancer. Our previous study revealed that the p53 gene is frequently mutated with a distinct nucleotide substitution pattern in small cell lung cancer specimens in Japanese patients. In this study, we examined 30 primary, resected non-small cell lung cancer samples in Japanese patients using complementary DNA-polymerase chain reaction and sequencing. Mutations changing the p53 coding sequence were found in 14 of 30 tumor samples (47%), while G:C to T:A transversions which are uncommon in other cancers such as colon cancer were the most frequently observed mutations, in agreement with an earlier report on non-small cell lung cancer in American patients. Furthermore, the present study shows for the first time that in univariate and multivariate analyses, the presence of p53 mutations is closely associated with lifetime cigarette consumption.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310070

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

Review 1.  Lung cancer in never-smokers.

Authors:  Chee-Keong Toh; Wan-Teck Lim
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

2.  Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.

Authors:  Alexis Desrichard; Fengshen Kuo; Diego Chowell; Ken-Wing Lee; Nadeem Riaz; Richard J Wong; Timothy A Chan; Luc G T Morris
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

3.  Sensitive and reliable PCR and sequencing used to detect p53 point mutations in fine needle aspirates of the breast.

Authors:  G P Howes; J Stephenson; S Humphreys
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

4.  Lung cancer andCYP1A1 orGSTM1 polymorphisms.

Authors:  Tsunehiro Oyama; Norio Kagawa; Yong-Dae Kim; Akiko Matsumoto; Toyohi Isse; Toshihiro Kawamoto
Journal:  Environ Health Prev Med       Date:  2003-01       Impact factor: 3.674

5.  Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra.

Authors:  T Hashimoto; Y Tokuchi; M Hayashi; Y Kobayashi; K Nishida; S Hayashi; Y Ishikawa; K Nakagawa; J Hayashi; E Tsuchiya
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 6.  Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers.

Authors:  Takayuki Fukui; Tetsuya Mitsudomi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-03-14

Review 7.  Clinical Outcomes of TP53 Mutations in Cancers.

Authors:  Ana I Robles; Jin Jen; Curtis C Harris
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

8.  Patterns of p53 mutations in squamous cell carcinoma of the lung. Acquisition at a relatively early age.

Authors:  J Zheng; Q Shu; Z H Li; J I Tsao; L M Weiss; D Shibata
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand bias.

Authors:  Ross R Keller; Shelley A Gestl; Amy Q Lu; Alicia Hoke; David J Feith; Edward J Gunther
Journal:  Carcinogenesis       Date:  2016-05-17       Impact factor: 4.944

10.  Biomolecular markers in cancer of the tongue.

Authors:  Daris Ferrari; Carla Codecà; Jessica Fiore; Laura Moneghini; Silvano Bosari; Paolo Foa
Journal:  J Oncol       Date:  2009-08-19       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.